Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BD Logo
BD Growth Score
76
CB Rank
6672
Heat Score
87
BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.
Founded
obfuscation
PublicPost-IPO Debt Franklin Lakes, New Jersey, United States10001+ www.bd.com
Health Care
Medical Device
Technical Support
Overview

BD
Total Funding
obfuscation
Growth Score
76
Heat Score
87

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score76
-12 pts
in past quarter
Heat Score 87
1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+4 more milestones
See more interactive data and historical milestones on desktop for the best experience

About BD

CB Rank
6672
BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.
Founded
obfuscation
PublicPost-IPO Debt Franklin Lakes, New Jersey, United States10001+ www.bd.com
Health Care
Medical Device
Technical Support

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Raphael Lozano
    Raphael Lozano: Principal Mechanical Engineer
    Past Role: BREWnGO Technologies, Founder and CTO
  • Photo of Richard Byrd
    Richard Byrd: Executive Vice President and President of the BD Interventional Segment
    Past Role: BD, WW President - BD Medication Management Solutions

Details

Legal Name Medicon Co., Ltd
Operating Status Active
Stock Symbol  NYSE:BDX
Company Type For Profit
Founders  Fairleigh Dickinson, Maxwell Becton
About the Company

BD is a global technology company that provides diagnostics and technologies for frontliners.

Through their solutions and services, they assist scientists in detecting diseases and advanced researchers' on developing diagnoses and therapeutics.

BD was established in 1897 by Farleigh Dickinson and Maxwell Becton in East Rutherford, New

Jersey.

Phone Number +1-201-847-6800
Predictions & Insights

Growth Insight

See this Growth Insight
BD is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

BD Vascular Access Management (VAM)
A system for managing vascular access devices to support infusion therapy and patient care.
Rotarex™ Atherectomy System
A medical device used to remove arterial blockages in peripheral artery disease treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - BD Logo
Post-IPO Debt - BD
—
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Steris Logo
Steris
Yes
Post-IPO Equity - BD Logo
Post-IPO Equity - BD
—
Steris Logo
Steris
Yes
Post-IPO Equity - BD Logo
Post-IPO Equity - BD
—
Steris Logo
Steris
Yes
Post-IPO Equity - BD Logo
Post-IPO Equity - BD
—
Steris Logo
Steris
Yes
Post-IPO Equity - BD Logo
Post-IPO Equity - BD
—
Steris Logo
Steris
Yes
Post-IPO Equity - BD Logo
Post-IPO Equity - BD
—

Investments

Number of Acquisitions 6

Investment Breakdown

Number of Acquisitions 6
Market Intelligence
People
View Profiles & Contacts
Headcount 10001+ Employee Profiles 19 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,047,902
-8.02%
 in past month

IT Spend

$738.1MThis year, BD is projected to spend $738.1M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Chicken Soup for the Soul Entertainment, Inc. (CSSE) Logo
Chicken Soup for the Soul Entertainment, Inc. (CSSE)
100
Exit Intent Logo
Exit Intent
100
Managed Security Services Logo
Managed Security Services
100

Active Website Tech Count

219BD is actively using 219 technologies for its website, according to BuiltWith. These include DNSSEC, Google Font API, and  LetsEncrypt.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 3
Which industries do these Sub-Organization operate in?
Parata Systems Logo
Parata SystemsSubsidiary
BD-Biosciences & Diagnostic Solutions business Logo
BD-Biosciences & Diagnostic Solutions businessSubsidiary
BD Advanced Patient Monitoring Logo
BD Advanced Patient MonitoringSubsidiary
Frequently Asked Questions

Where is BD's headquarters? BD is located in Franklin Lakes, New Jersey, United States.Who invested in BD? BD is funded by Steris.When was the last funding round for BD? BD closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are BD's competitors? Alternatives and possible competitors to BD may include Boston Scientific, Imperative Care, and  Inflammatix.How much funding has BD raised to date? BD has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|